Works matching IS 1365-7852 AND VI 18 AND IP 2 AND DT 2015

Results: 16

Association of fatty-acid synthase polymorphisms and expression with outcomes after radical prostatectomy.

Published in:

Prostate Cancer & Prostatic Diseases, 2015, v. 18, n. 2, p. 182, doi. 10.1038/pcan.2015.11

By:

Cheng, J.;
Ondracek, R. P.;
Mehedint, D. C.;
Kasza, K. A.;
Xu, B.;
Gill, S.;
Azabdaftari, G.;
Yao, S.;
Morrison, C. D.;
Mohler, J. L.;
Marshall, J. R.

Publication type:

Article

Metabolic syndrome, dyslipidemia and prostate cancer recurrence after primary surgery or radiation in a veterans cohort.

Published in:

Prostate Cancer & Prostatic Diseases, 2015, v. 18, n. 2, p. 190, doi. 10.1038/pcan.2015.12

By:

Macleod, L. C.;
Chery, L. J.;
Hu, E. Y. C.;
Zeliadt, S. B.;
Holt, S. K.;
Lin, D. W.;
Porter, M. P.;
Gore, J. L.;
Wright, J. L.

Publication type:

Article

ERRATUM.

Published in:: 2015
Publication type:: Correction Notice

Multiparametric MRI for detection of radiorecurrent prostate cancer: added value of apparent diffusion coefficient maps and dynamic contrast-enhanced images.

Published in:

Prostate Cancer & Prostatic Diseases, 2015, v. 18, n. 2, p. 128, doi. 10.1038/pcan.2014.55

By:

Abd-Alazeez, M.;
Ramachandran, N.;
Dikaios, N.;
Ahmed, H. U.;
Emberton, M.;
Kirkham, A.;
Arya, M.;
Taylor, S.;
Halligan, S.;
Punwani, S.

Publication type:

Article

Impact of metformin on clinical outcomes among men with prostate cancer: a systematic review and meta-analysis.

Published in:

Prostate Cancer & Prostatic Diseases, 2015, v. 18, n. 2, p. 110, doi. 10.1038/pcan.2014.52

By:

Raval, A. D.;
Thakker, D.;
Vyas, A.;
Salkini, M.;
Madhavan, S.;
Sambamoorthi, U.

Publication type:

Article

Gonadotropin-releasing hormone agonist overuse: urologists' response to reimbursement and characteristics associated with persistent overuse.

Published in:

Prostate Cancer & Prostatic Diseases, 2015, v. 18, n. 2, p. 173, doi. 10.1038/pcan.2015.10

By:

Ellis, S. D.;
Nielsen, M. E.;
Carpenter, W. R.;
Jackson, G. L.;
Wheeler, S. B.;
Liu, H.;
Weinberger, M.

Publication type:

Article

Multidrug and toxin extrusion 1 and human organic cation transporter 1 polymorphisms in patients with castration-resistant prostate cancer receiving metformin (SAKK 08/09).

Published in:

Prostate Cancer & Prostatic Diseases, 2015, v. 18, n. 2, p. 167, doi. 10.1038/pcan.2015.8

By:

Joerger, M.;
van Schaik, R. H. N.;
Becker, M. L.;
Hayoz, S.;
Pollak, M.;
Cathomas, R.;
Winterhalder, R.;
Gillessen, S.;
Rothermundt, C.

Publication type:

Article

Reversal of PSA progression on abiraterone acetate through the administration with food in men with metastatic castration-resistant prostate cancer.

Published in:

Prostate Cancer & Prostatic Diseases, 2015, v. 18, n. 2, p. 161, doi. 10.1038/pcan.2015.7

By:

Stover, J. T.;
Moore, R. A.;
Davis, K.;
Harrison, M. R.;
Armstrong, A. J.

Publication type:

Article

Computed high b-value diffusion-weighted imaging improves lesion contrast and conspicuity in prostate cancer.

Published in:

Prostate Cancer & Prostatic Diseases, 2015, v. 18, n. 2, p. 155, doi. 10.1038/pcan.2015.5

By:

Feuerlein, S.;
Davenport, M. S.;
Krishnaraj, A.;
Merkle, E. M.;
Gupta, R. T.

Publication type:

Article

Nationally representative trends and geographic variation in treatment of localized prostate cancer: the Urologic Diseases in America project.

Published in:

Prostate Cancer & Prostatic Diseases, 2015, v. 18, n. 2, p. 149, doi. 10.1038/pcan.2015.3

By:

Cary, K. C.;
Punnen, S.;
Odisho, A. Y.;
Litwin, M. S.;
Saigal, C. S.;
Cooperberg, M. R.

Publication type:

Article

Prospective evaluation of low-dose ketoconazole plus hydrocortisone in docetaxel pre-treated castration-resistant prostate cancer patients.

Published in:

Prostate Cancer & Prostatic Diseases, 2015, v. 18, n. 2, p. 144, doi. 10.1038/pcan.2015.2

By:

Lo, E. N.;
Beckett, L. A.;
Pan, C.-X.;
Robles, D.;
Suga, J. M.;
Sands, J. M.;
Lara Jr, P. N.

Publication type:

Article

A review of rectal toxicity following permanent low dose-rate prostate brachytherapy and the potential value of biodegradable rectal spacers.

Published in:

Prostate Cancer & Prostatic Diseases, 2015, v. 18, n. 2, p. 96, doi. 10.1038/pcan.2015.4

By:

Schutzer, M. E.;
Orio, P. F.;
Biagioli, M. C.;
Asher, D. A.;
Lomas, H.;
Moghanaki, D.

Publication type:

Article

Evaluation of models predicting insignificant prostate cancer to select men for active surveillance of prostate cancer.

Published in:

Prostate Cancer & Prostatic Diseases, 2015, v. 18, n. 2, p. 137, doi. 10.1038/pcan.2015.1

By:

Wong, L.-M.;
Neal, D. E.;
Finelli, A.;
Davis, S.;
Bonner, C.;
Kapoor, J.;
Trachtenberg, J.;
Thomas, B.;
Hovens, C. M.;
Costello, A. J.;
Corcoran, N. M.

Publication type:

Article

Re-purposing cryoablation: a combinatorial 'therapy' for the destruction of tissue.

Published in:

Prostate Cancer & Prostatic Diseases, 2015, v. 18, n. 2, p. 87, doi. 10.1038/pcan.2014.54

By:

Baust, J. G.;
Bischof, J. C.;
Jiang-Hughes, S.;
Polascik, T. J.;
Rukstalis, D. B.;
Gage, A. A.;
Baust, J. M.

Publication type:

Article

Activity of enzamtamide in men with metastatic castration-resistant prostate cancer is affected by prior treatment with abiraterone and/or docetaxel.

Published in:

Prostate Cancer & Prostatic Diseases, 2015, v. 18, n. 2, p. 122, doi. 10.1038/pcan.2014.53

By:

Cheng, H. H.;
Gulati, R.;
Azad, A.;
Nadal, R.;
Twardowski, P.;
Vaishampayan, U. N.;
Agarwal, N.;
Heath, E. I.;
Pal, S. K.;
Rehman, H.-t.;
Leiter, A.;
Batten, J. A.;
Montgomery, R. B.;
Galsky, M. D.;
Antonarakis, E. S.;
Chi, K. N.;
Yu, E. Y.

Publication type:

Article

Racial parity in tumor burden, treatment choice and survival outcomes in men with prostate cancer in the VA healthcare system.

Published in:

Prostate Cancer & Prostatic Diseases, 2015, v. 18, n. 2, p. 104, doi. 10.1038/pcan.2014.51

By:

Daskivich, T. J.;
Kwan, L.;
Dash, A.;
Litwin, M. S.

Publication type:

Article